X
20
Glenmark Life Sciences Ltd, based in India, is a pharmaceutical company.
One of their notable products is APREMILAST, with a corresponding US DMF Number 31490.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 25, 2017, and payment made on April 03, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II